Sinopep-Allsino Biopharmaceutical Co Ltd.is a premier pharmaceutical company mainly focused the research and development (R&D), production, sales and technical services of peptide and small molecule drugs. Sinopep is a National High-tech and provincial science and technology enterprise, established in April 2009, located in the Lianyungang National Economic and Technological Development Zone. On May 20th, Sinopep-Allsino was listed on the STAR Market of Shanghai Stock Exchange (Stock Name/Code: Sinopep/ 688076). Currently we have more than 900 employees.Through technological innovation, the company is committed to breaking through the technical bottleneck of drug R&D and production, building a whole industry chain from pharmaceutical intermediates, APIs to formulation, and providing green, low-cost, high-quality, and efficient pharmaceutical-related products and technical services for the worldwide partners.